Overview

Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)

Status:
Completed

Trial end date:
2018-01-02

Target enrollment:

Participant gender:

Summary

The purpose of this study was to assess the efficacy, safety and tolerability of mirabegron versus placebo in the treatment of older adult subjects with OAB.

Phase:

Phase 4

Details

Lead Sponsor:

Astellas Pharma Global Development, Inc.

Treatments:

Mirabegron